ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000624.1|Salivaricin_1 # 313 # 570 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.326	BGC0000624.1|Salivaricin_1 	313	570	+	Loose	500	28.8758	CARB-9	23.46	3002248	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGCTAAAAAAACTATGGGAGACTTGGTTGGATGGTGGATTTATTAGAGGAAAGAAGAGATATGTTATTGCTCCAGTTATTTGGGCACTGTTGATTCCACTAGGAATATGGCTGTTTGGTAATGAGGAAATGTCTTATTTAGATTATATTCAAACGCCTAAAATGATAATAGTTACTATTTTTTGTCTAGTAGGTGGTAGTACACTACTTTACTTATTAGATACTGCGATGAAAGTAAATAAACATATGAAAGGATGA	MLKKLWETWLDGGFIRGKKRYVIAPVIWALLIPLGIWLFGNEEMSYLDYIQTPKMIIVTIFCLVGGSTLLYLLDTAMKVNKHMKG	MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQRFPLTSTFKTIACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVGKPITLSDACFATMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNAITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVTWSIADRSGAGGFGARSITAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR	29.51	gnl|BL_ORD_ID|736|hsp_num:0	780		
BGC0000624.1|Salivaricin_2 # 576 # 770 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.441	BGC0000624.1|Salivaricin_2 	576	770	+	Loose	750	21.1718	patA	30.77	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATGAAGGAATTTACAGTATTGACAGAATGTGAGTTAGCAAAGGTTGATGGTGGGAAACGTGGTCCTAACTGTGTAGGTAACTTCTTAGGTGGTCTATTTGCTGGAGCAGCTGCAGGAGTTCCACTTGGACCAGCTGGTATTGTAGGTGGAGCAAACTTAGGAATGGTAGGCGGAGCACTTACTTGTTTATAA	MMKEFTVLTECELAKVDGGKRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	11.35	gnl|BL_ORD_ID|1953|hsp_num:0	2081		
BGC0000624.1|Salivaricin_3 # 788 # 994 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.430	BGC0000624.1|Salivaricin_3 	788	994	+	Loose	500	24.6386	APH(3'')-Ia	48.28	3002638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGAAAAATCTAGATAAAAGATTCACAATTATGACTGAAGATAACTTAGCATCAGTAAATGGTGGTAAAAATGGTTATGGTGGTAGTGGAAATCGCTGGGTTCACTGTGGAGCTGGCATCGTAGGTGGAGCTTTAATTGGAGCTATCGGTGGACCCTGGTCAGCCGTAGCGGGTGGAATTTCTGGTGGTTTTACAAGTTGCCGTTAA	MKNLDKRFTIMTEDNLASVNGGKNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFTSCR	MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDRIAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHEVPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQEAADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERARFADAAFAERYGIAPDPERLRFYLHLDPLTWG	25.00	gnl|BL_ORD_ID|1816|hsp_num:0	1923		
BGC0000624.1|Salivaricin_4 # 1137 # 1304 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.286	BGC0000624.1|Salivaricin_4 	1137	1304	+	Loose	600	23.8682	IMI-8	46.88	3003142	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGGTATTTTGGGTTACTGTAATAGTTGCATATAGTATCTTTATAAGTATTTATACTAGTCTAAAAGAAGATGGGCATTATAAGTTATTTGATGAGAAAGTCATAGAAAAGAATAAGAAAATAAGTTATGTGAGAGCGTGGTTGTTAAATTTTATGTGGTGGCTATAG	MVFWVTVIVAYSIFISIYTSLKEDGHYKLFDEKVIEKNKKISYVRAWLLNFMWWL	MSINAKKSKAAVFLSYFLIPISFYSQADTNAMDEIKKLETGFGGRVGVYALDTGSGKSFSYRANERFPLCSSFKGFLAAAVLKGSQDNQLNINEIVNYNKRSLEPHSPITQKYKENGMSLGDMAAAALQYSDNGAANIILERYIGGPEGMTNFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVGKSLKNLALGNILNDHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGTCGAYGTANDYAVVWPKNRAPLIISVYTTKSEKEAKHDEKVIEEASRIAITHLK	18.84	gnl|BL_ORD_ID|2643|hsp_num:0	3617		
BGC0000624.1|Salivaricin_5 # 1424 # 1540 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333	BGC0000624.1|Salivaricin_5 	1424	1540	+	Loose	880	20.4014	tet(L)	60.0	3000179	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGTTTGAAGTGTTAACAGAAAAGAAGTTACAGAAAATAGCTGGGGGAGCAACCAAAAAGGGTGGCTTTAAAAGATGGCAATGTATATTCACATTTTTTGGTGTTTGTAAATAA	MKFEVLTEKKLQKIAGGATKKGGFKRWQCIFTFFGVCK	MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFMLTFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAFPALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIRKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIFPGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLGGLLFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPMEVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF	8.30	gnl|BL_ORD_ID|2412|hsp_num:0	1897		
BGC0000624.1|Salivaricin_6 # 1540 # 2829 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.255	BGC0000624.1|Salivaricin_6 	1540	2829	+	Loose	700	28.1054	vanSE	32.08	3002935	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGTTAATTTAAATTCAACATCTGGTTATATAGTAGCTACACTAATTTTATTTATAAATACTTTTTGTAGATATAGTTTTTTTTATCTTTTGACCCCTACTAGGAAAAGTAAGAAGTATAATTTATTATTTATACTTCTTACTTTTCCTGTAATTCTTTTAATTAATGGTGTTGGAGATATTATTGGTTTTTTTGCACCATTTATTGAAATTTTTATTTTTTATATTGTATACAGACAACTAACTTTGGATTACAGATTATGTGGAAGGTTGTTAATGCTAGATTTATTTTCCTACATAACATTCGGTGCTTCAGCATTATTTTTTACATTATTTACAAATTATTACACAATGGTCAGTGTGATAATATTAGATGTGTCATTAAACATTTTTGAATATATAATTTTAACAAAGACGACTATAATAGAGAAACTAGATGATGAGTATGGATTATTGTATTTTTATTTAATTTTATACATATGGATTAGTTCAATGGTTATTTACTATCTAACAACATATGTATTTAATATAGATGCAGTATCGTATATTATAGCTATGGTAGTTGTTGTTAGCCAATTGTTCTTTTCATTATTTGTATATTCCATTAATAAGAAAATACGGCAGGATAAATTAAGTTTACAACAAATTAATGATCTAAAAATTTATACACAACAGTTAGAAAGTAGCCAGCGAGGTTTACGTAAATTTAAGCACGATTATCAAAATATGCTATTAAGCTTGAAACTCAGTGCAAAAAAAAGTCATGATAAAGAGTTAATAGATAAACTAGCTGAATATTCAAGTAAGACTTTAGAAGATAAAGTATTATGGCAGTTTAATGATGTTGACAATGTTAAAGATGAATTATTAAAGAGTCTATTTATCAGTAAGTTGAATAGAATCTTTCAAAACAATATTCAATATTCTTTTGAATGTCGAATTGTGATAGAAAACTTGTCGAATAAGTATAACTCGTTTGACATTGTTAGAATATTAGGAATTGTGTACGATAATGCAATTGAAGAAAGTCTTGAGTTTGGTGATGAAGCTAAGATAGATACTATGATTTATCAAGAAAATGGTGAACTTGAAATTGAGATTAGAAATCGTTATCGAGATACCGATCTAACAATTCAAGATATAAAAAAATCAGGTTTTACAACTAAGAAGAATCATGACGGATTAGGATTAGCTAATATAGAAGAATTAAGTCAATCTTATAATGATATTTTTATTAATTATCAAATTAAAGATGGTTGGTTTACTTTCCTTATGGTTATGAGCATTTAA	MVNLNSTSGYIVATLILFINTFCRYSFFYLLTPTRKSKKYNLLFILLTFPVILLINGVGDIIGFFAPFIEIFIFYIVYRQLTLDYRLCGRLLMLDLFSYITFGASALFFTLFTNYYTMVSVIILDVSLNIFEYIILTKTTIIEKLDDEYGLLYFYLILYIWISSMVIYYLTTYVFNIDAVSYIIAMVVVVSQLFFSLFVYSINKKIRQDKLSLQQINDLKIYTQQLESSQRGLRKFKHDYQNMLLSLKLSAKKSHDKELIDKLAEYSSKTLEDKVLWQFNDVDNVKDELLKSLFISKLNRIFQNNIQYSFECRIVIENLSNKYNSFDIVRILGIVYDNAIEESLEFGDEAKIDTMIYQENGELEIEIRNRYRDTDLTIQDIKKSGFTTKKNHDGLGLANIEELSQSYNDIFINYQIKDGWFTFLMVMSI	MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVWLIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRIDSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYIDIISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDFKIEPNVFVQLNINKFERVLDNLIRNAISYSLNDTTIKLTLEKVDEKVVVSVGNITDKVSEKDIDQLFEPFYRGDKSRNTKTGNAGLGLAIAKQIISEHGGTIEAELQNNDFKVSIIL	120.17	gnl|BL_ORD_ID|1477|hsp_num:0	1571		
BGC0000624.1|Salivaricin_7 # 2843 # 3637 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.298	BGC0000624.1|Salivaricin_7 	2843	3637	+	Loose	600	30.4166	cipA	29.03	3003907	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	TTGGAAGAATATGGAATTATTATTTGTGACGATGAGAAGGATCAAGTTAGAAGGATACATGATCTAGTTAAATATGCTATTTGGTCTTTAGAAGATTCTGCTGACAGTAAAGGTAAAAAATTTAAAATAACTTTGGAAGCTAATAGTTATATTGAAGTAGCCGATTATTTGGAAGATAACAAAGTAGATAGTGGAGTTTATTTTTTAGATATCGAGCTTAGTAGGGATAGAGCAGATAAAGATGGCATAGATTTAGCTGAATTTATTAGACAAAGAGATCCAAATGCACAGATAATTTTTATTACTGCTTATGAAAATCTAGCAGCAATGACCTATCGACGTCGCACAGGAGCATTGAATTTTATTACTAAAAACGATAGTGATGAAGTGATTCAAAAGAGACTAAATGAAACTTTATCATTAGCTGCAAGGAGAATTAGGGAATCTCATGCCATAAAGAAAATGACATTTAGTTATAAAATGGGCAGAAGAATTATTAACGAAAATATCAATGATATTCTATATATTATTACCACTCCTAAGTCACATAGATTAAAAATAGTTACAGTTAATGGTATGGGTGAGTTTACAGGCGATATTAAGAAGTTAGAGGCAGAAAATGATTTTCTAGAAAAAATATCACAATCTTGTTTAGCTAATCCAAGTAATATTGTTGAAATTAACCTGTCAACAAGGGTTATTTCTTTTAAAGATGGATATAAAGAGACTTTTCCTAGAAGAAGTAAGGCTAAAATGAAAAGTTTGATTGAAAGGTATAATTTGAAAACAGTTTAA	MEEYGIIICDDEKDQVRRIHDLVKYAIWSLEDSADSKGKKFKITLEANSYIEVADYLEDNKVDSGVYFLDIELSRDRADKDGIDLAEFIRQRDPNAQIIFITAYENLAAMTYRRRTGALNFITKNDSDEVIQKRLNETLSLAARRIRESHAIKKMTFSYKMGRRIINENINDILYIITTPKSHRLKIVTVNGMGEFTGDIKKLEAENDFLEKISQSCLANPSNIVEINLSTRVISFKDGYKETFPRRSKAKMKSLIERYNLKTV	MKYLSKYEKIRKILSALNQPNYRYSQITEAIFKNKIGNFEAMNNLPKPVRNELIKELGNNVLSITPKMEQKSNQVSKILFAIPGDEYIESVRLSYQTGWESYCISSQCGCGFGCTFCATGTLGLKRNLTTDEITDQLLYFTLNNHPLDSVSFMGMGEALANPYVFDALHLLTDPKLFGLGHRRITVSTIGLLPGVKKLTKEFPQINLTFSLHSPFHDQRSELMPINNHFPLEEVMTVLDEHIQQTKRKVYIAYILLRGINDSTKHAKAVADLLRERGSWEHLYHVNLIPYNSTDATSQSFVESDQNSINMFLRILKSKGIHVTVRTQFGSDINAACGQLYGSNGNI	76.30	gnl|BL_ORD_ID|2228|hsp_num:0	2386		
BGC0000624.1|Salivaricin_8 # 3645 # 3914 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.274	BGC0000624.1|Salivaricin_8 	3645	3914	+	Loose	900	23.483	lmrB	32.56	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTTTATTGATATAGGTGGTGAAAATGACATGGTAGAAACAGGTATTATTATATTGCTAATTGTAGGGTTTATGGCAATTTCAAGGTTGAAAGTAAATTTTACAAGAAATAGTAAGTATGCAGGTTTTCTATTGTTAATATTACTGAATTTAAATGGGCTTATGCGAACTCCTATGTTAACAATGAGAAGTTTAATCTTATTGGGAACATTGATGATTTTTGTAGTTATGTTGATTAAAGAAATTAGACAAAGTAGAAAATATAGTTAA	MFIDIGGENDMVETGIIILLIVGFMAISRLKVNFTRNSKYAGFLLLILLNLNGLMRTPMLTMRSLILLGTLMIFVVMLIKEIRQSRKYS	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	18.66	gnl|BL_ORD_ID|554|hsp_num:0	592		
BGC0000624.1|Salivaricin_9 # 4064 # 6223 # 1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.305	BGC0000624.1|Salivaricin_9 	4064	6223	+	Loose	1190	226.483	novA	26.27	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGTTAAGAAAGTATCGAAAAGATTACGTTTCACAAGTAGACGAATCTGATTGTGGCGTGGCTTCGTTGGCTATGATTTTGAAACACTATGGATCAGCACTATCATTAGCGTATTTAAGGAACATTGCTAAGACAACAATGGAGGGGACTACAGCTTTAGGTCTTGTTAAGACAGCACAGGCTTTAGGAATGGAAACACAAGCCGTAAAAGCTGATATGTCTCTTTTTGGAATGAAAGACATTACATATCCATTTATTGTACATGTGGTTAAAGAAGAGACGTTATTACATTATTATGTAGTATTGAAAGCAACGCCTAGATATATTTTAATTGCTGATCCAGCTCCAGATGTAGGGATAACTAAAATGTCGTATGAACGTTTTGAAAAAGAATGGACAGGGATTACTTTATTCATCGTTCCAGGAATTGAATACAAGCCGACAAAAGAGACTAGACAATCATTAATATCACTATTTAGTAAATTATTTAAGCAAAAGCAACTAATAGTTAATATTGTATTGGCAGCTTTGTTAATTACAATTATTAGTATATTGGGATCATATTTTTTACAGGGAATAATTGATACATATATTCCTAATGGTATGCATAGTACACTGGCAATTATTGCTTTGGGATTACTAGTAATATATGTGTTCAATTCAATTTTTACATATGCAAGGGATTTTTTATTAGCAATTTTAGGACAACGACTTTCGATTGAAATTATTTTAAGTTATATTAGACATATTTTTGAGTTGCCTATGGAATTTTTTGCGACCAGAAAAACTGGGGAAATAGTTTCTCGTTTCAATGATGCTAGTAAAATTATAGATGCTTTAGCAAGTACTGTGGTATCTATTTTTTTAGATGTAAGTATTGTAGTTATTATGGGAATAATCTTGGCTATTCAAAATCTTAAATTACTAGGAATAACTCTTATCACACTTCCAATTTACACGATTATTATTCTTACATTTACAAAGGCATTTGAAAGATTGAATAATAAACAAATGGAAAGTAATGCGATACTTAGTTCATCTATTATTGAAGATATTCAAGGAATAGAAACAATAAAAGCCTTAAACAGCGAACAAATGCGTTACCGCAAAATTGATAGTCAATTTGTGGACTATTTGCGTAAATCGTTAGCATATATAAAAACAGACTCGTTGCAACAAGCATTAAAGTTATTTATTCAACAAACATTAAATGTTATAGTCCTATGGTTAGGGGCAAATCTGGTAATTAGTAATCAACTCTCTATAGGACAATTAATGACTTTTAACGCACTATTAAGTTATTTTGTGAATCCATTACAAAATATCATAAATTTACAGCCAAAATTGCAGAGTGCAAGGGTAGCTCACAATCGTTTGAATGAGGTTTACTTGGTTGAAAGTGAATTTAAAGATAGAAAGGCTGTTCATGATGTTACTCAACTTCAAGGAGACATTATATTTAAAGATGTTGATTATCACTATGGTTATGGTGAAAATGTTTTGGATAAGGTTAATTTGACTTTAAAACAGGGAGAAAAACTAACTATAGTAGGTATGAGTGGCTCTGGCAAATCAACGTTAGTTAAACTATTGGTGAATTTTTTTGCTCCAGTTTCAGGGAGTATAAAACTAAATAATCATGATATTAATAATATTGATAAGCATGCACTGCGTTCCTATATTAATTATATACCACAGAATCCATATATTTTTACCGGGACAATAGAAGATAATCTTAGACTAGGTAATCGATCTAATGTGACTGATGAGGATATTCTTATGGCTTGTAAAATAGCAATGATTGATATAGATATAGCGAAGATGCCACTACAATTAAAAACTGAATTAGATGAAAATGCTAATATTTTATCAGGTGGACAAAAACAAAGAATTACAATTGCTAGAGCCTTATTATCTCCAGCACAAGTATTGATTTTTGATGAATCTACAAGTGGGTTAGATGCTATTACGGAGAAAAAACTAATTGATAATTTAATGAAATTAAAGTCAAAAACTATAATTTTTATTGCACATAGATTATCTATAGCTAAGCGAACAAATAATATTCTAGTATTAGATAGCGGAAAAATTGTAGAAAAGGGTAGACATGATGAATTATTAGCTAAAAAAGGATACTACTACAATTTAGTTAATAGTTAG	MLRKYRKDYVSQVDESDCGVASLAMILKHYGSALSLAYLRNIAKTTMEGTTALGLVKTAQALGMETQAVKADMSLFGMKDITYPFIVHVVKEETLLHYYVVLKATPRYILIADPAPDVGITKMSYERFEKEWTGITLFIVPGIEYKPTKETRQSLISLFSKLFKQKQLIVNIVLAALLITIISILGSYFLQGIIDTYIPNGMHSTLAIIALGLLVIYVFNSIFTYARDFLLAILGQRLSIEIILSYIRHIFELPMEFFATRKTGEIVSRFNDASKIIDALASTVVSIFLDVSIVVIMGIILAIQNLKLLGITLITLPIYTIIILTFTKAFERLNNKQMESNAILSSSIIEDIQGIETIKALNSEQMRYRKIDSQFVDYLRKSLAYIKTDSLQQALKLFIQQTLNVIVLWLGANLVISNQLSIGQLMTFNALLSYFVNPLQNIINLQPKLQSARVAHNRLNEVYLVESEFKDRKAVHDVTQLQGDIIFKDVDYHYGYGENVLDKVNLTLKQGEKLTIVGMSGSGKSTLVKLLVNFFAPVSGSIKLNNHDINNIDKHALRSYINYIPQNPYIFTGTIEDNLRLGNRSNVTDEDILMACKIAMIDIDIAKMPLQLKTELDENANILSGGQKQRITIARALLSPAQVLIFDESTSGLDAITEKKLIDNLMKLKSKTIIFIAHRLSIAKRTNNILVLDSGKIVEKGRHDELLAKKGYYYNLVNS	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	116.91	gnl|BL_ORD_ID|1140|hsp_num:0	1210		
BGC0000624.1|Salivaricin_10 # 6240 # 7394 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.278	BGC0000624.1|Salivaricin_10 	6240	7394	+	Loose	800	26.9498	adeI	26.7	3000780	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAGATAAATTTTTAGAAAGCAGCGAATTTTATTCAGCTAGATTTAGAAACTTTTCAACTATGATTATTATTCCTTTTACAATTTTATTGTTGGTGGTAGTAATTTTTAGCTTTTTTGGAAAAAAGGAGATAACTATCCAAGGTGCAGGAACACTTGAGGCATTGGGAAATAATCCTGTTATTCAATCAACTGTAAATAGTCCTATTGAAAAAAATTATTTAAAAGAAGGAAAGTATGTAAAAAAAGGAGATACATTACTTATTTATAATAATGTGAGTATACAAGATAAGGGGAAACTGTATAATTCACAAAAAGAAATCTTAGATAGACAGTTGGCAGCTTTGAACTTACTTAAACAAGGTGTTCAAGACAATCATGATTCTTTTGGAGAAGATGATGAATTTGGTTATCGTAATGATTTAAAGAGTTACCTACAGCAAAGGAATACGTATTTAACAGAAAATACAATGATCCAGGATAAATCTAAAAACGACAAAGCCAAACAAAGTTCGATTAATAATGAGTTGAAGAAACAAAGTGGGTCTGCTACAAGTATAGCTGATTTTGATTCGTCTAAATACGATATTGAGATAAACAATCAAAAAATAAGTGATTTACAGTCAAGTAAGTTAAGTTCTATTGATCAAGAAATTATAAAAATCAAGCAAAATATTTCAGAATTGAACGCTAATATTAATGAAAATAATAATACTAATAGAGAGTATAAGGTAAAGGCTGTTAGAGACGGAATTTTACATATTAACGATGAGTATAGTGAAAGTCATTATATAAGTGCAGGGGCTAATTTAGCTCAGATACTACCAGTTTTGAAAAATCAAAAAACTTTAAAAGTAAAGGCATATGTAAGTACAGCAGATATTTCCTCCATAAAAGTAGGGCAAAAAGTAAGATTCAAAGTAACTAGAAACGTATCTAAACCTATTATTTTGACTGGAAAAATATATAAGATATCGATTTCTCCAGTAGAGATAGGAAAAGAAAATTATTATCAAATTGAAGCTAAAACAGATATTGAAAATACTAATAAGGATTTATTGAAGTATGGTATGCAAGGACGAATGGTTGTAATTACAGGAAAAACAACATTTTTTGAATATTATAAGAATAAGTTATTTAATATTAAACAATAA	MEDKFLESSEFYSARFRNFSTMIIIPFTILLLVVVIFSFFGKKEITIQGAGTLEALGNNPVIQSTVNSPIEKNYLKEGKYVKKGDTLLIYNNVSIQDKGKLYNSQKEILDRQLAALNLLKQGVQDNHDSFGEDDEFGYRNDLKSYLQQRNTYLTENTMIQDKSKNDKAKQSSINNELKKQSGSATSIADFDSSKYDIEINNQKISDLQSSKLSSIDQEIIKIKQNISELNANINENNNTNREYKVKAVRDGILHINDEYSESHYISAGANLAQILPVLKNQKTLKVKAYVSTADISSIKVGQKVRFKVTRNVSKPIILTGKIYKISISPVEIGKENYYQIEAKTDIENTNKDLLKYGMQGRMVVITGKTTFFEYYKNKLFNIKQ	MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSVELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQQQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYSTIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGSLNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTAQIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKAGDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA	92.31	gnl|BL_ORD_ID|1385|hsp_num:0	1471		
BGC0000624.1|Salivaricin_11 # 7486 # 7740 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.306	BGC0000624.1|Salivaricin_11 	7486	7740	+	Loose	400	24.2534	vanRN	40.0	3002929	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAGTGACATGGAAGAAAAATTTTTGAATTATGATATACCCAATTTTGTAAAAGAATCACCTAATTACCTAAAACTATTTGAAAAAGAACGTATCATCCTAAAGAATAATCATGATAAATGGGGGATCTACTTTAGTGAGGAATTGGGGCATCCATTGGAATATAAGGAAAATTCAGGAAAAGTAGATTATATATATGATTTTTTCTTGGAAGCCTACTCTCAAGCTGATAATGACGGAGAAGTTTGGTTTTAA	MSDMEEKFLNYDIPNFVKESPNYLKLFEKERIILKNNHDKWGIYFSEELGHPLEYKENSGKVDYIYDFFLEAYSQADNDGEVWF	MDTIVIVDDEKEIANLMTTFLENEGFKVMTFYSGKEALDYIDQNGASLAILDVMLPDLDGFQILQHIRQTFFFPVLMLTAKGENLDKITGLTLGADDYITKPFNPLEVVARVKTQLRRTQRYDQPSHSQSDEEFTKEGLVLKKNSHQVFLFDQEVLITPLEFKILLYLFEHQGTVVSSETLFEEVWQEKYLDNNNTVMAHIARLREKLGEKPRKPKYIKTVWGVGYIIEK	36.52	gnl|BL_ORD_ID|1149|hsp_num:0	1219		
